- Singh VK, Haupt ME, Geller DE, Hall JA, Quintana Diez PM. Less common etiologies if exocrine pancreatic insufficency. World J Gastroenterol 2017; 23(39):7059-7076
We would like to inform you that Viatris, the marketing authorisation holder for Creon® has decided to increase the capsule length of Creon® 25000 from 21.7mm to 24.2mm. The diameter of the capsule will not change.
The new size of Creon® 25000 capsule does not affect the efficacy of the product and should not have an impact on the patient’s ability to swallow the capsules whole.